203 related articles for article (PubMed ID: 23881886)
21. Could spice drugs induce psychosis with abnormal movements similar to catatonia?
Haro G; Ripoll C; Ibáñez M; Orengo T; Liaño VM; Meneu E; Hernández F; Traver F
Psychiatry; 2014; 77(2):206-8. PubMed ID: 24865202
[No Abstract] [Full Text] [Related]
22. [A case of acute psychotic episode after a single dose of ecstasy].
Vaiva G; Bailly D; Boss V; Thomas P; Lestavel P; Goudemand M
Encephale; 2001; 27(2):198-202. PubMed ID: 11407274
[TBL] [Abstract][Full Text] [Related]
23. Schizotypy and psychosis-like experiences from recreational cannabis in a non-clinical sample.
Barkus E; Lewis S
Psychol Med; 2008 Sep; 38(9):1267-76. PubMed ID: 18205966
[TBL] [Abstract][Full Text] [Related]
24. Psychopathological symptoms associated with synthetic cannabinoid use: a comparison with natural cannabis.
Mensen VT; Vreeker A; Nordgren J; Atkinson A; de la Torre R; Farré M; Ramaekers JG; Brunt TM
Psychopharmacology (Berl); 2019 Sep; 236(9):2677-2685. PubMed ID: 30968175
[TBL] [Abstract][Full Text] [Related]
25. The Relevance of Sex in the Association of Synthetic Cannabinoid Use With Psychosis and Agitation in an Inpatient Population.
Bassir Nia A; Mann CL; Spriggs S; DeFrancisco DR; Carbonaro S; Parvez L; Galynker II; Perkel CA; Hurd YL
J Clin Psychiatry; 2019 Jul; 80(4):. PubMed ID: 31265768
[TBL] [Abstract][Full Text] [Related]
26. [Differential approaches to the treatment of acute psychosis due to the use of synthetic cannabinoids].
Kekelidze ZI; Klimenko TV; Kozlov AA; Shakhova SM
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(12):21-26. PubMed ID: 29376979
[TBL] [Abstract][Full Text] [Related]
27. New-Onset Prolonged Psychosis Following Synthetic Cannabinoid Use in an Older Patient: A Case Report.
Alhassan A; Prahad SR; Burk BG; Fargason RE; Birur B
Psychopharmacol Bull; 2024 Mar; 54(1):33-39. PubMed ID: 38449474
[TBL] [Abstract][Full Text] [Related]
28. First episode psychosis with and without the use of cannabis and synthetic cannabinoids: Psychopathology, global functioning and suicidal ideation and antipsychotic effectiveness.
Ricci V; Ceci F; Di Carlo F; Di Muzio I; Ciavoni L; Santangelo M; Di Salvo G; Pettorruso M; Martinotti G; Maina G
Psychiatry Res; 2023 Feb; 320():115053. PubMed ID: 36682093
[TBL] [Abstract][Full Text] [Related]
29. Case report: adverse reaction to synthetic marijuana.
Faircloth J; Khandheria B; Shum S
Am J Addict; 2012; 21(3):289-90. PubMed ID: 22494237
[No Abstract] [Full Text] [Related]
30. Cannabis use correlates with schizotypy in healthy people.
Williams JH; Wellman NA; Rawlins JN
Addiction; 1996 Jun; 91(6):869-77. PubMed ID: 8696249
[TBL] [Abstract][Full Text] [Related]
31. Synthetic Cannabinoids: Use and Predictors in a Community Sample of Young Adults.
Caviness CM; Tzilos G; Anderson BJ; Stein MD
Subst Abus; 2015; 36(3):368-73. PubMed ID: 25222129
[TBL] [Abstract][Full Text] [Related]
32. Teens and Spice: A Review of Adolescent Fatalities Associated with Synthetic Cannabinoid Use.
Paul ABM; Simms L; Amini S; Paul AE
J Forensic Sci; 2018 Jul; 63(4):1321-1324. PubMed ID: 29194599
[TBL] [Abstract][Full Text] [Related]
33. Risky recreation: synthetic cannabinoids have dangerous effects.
McGuinness TM; Newell D
J Psychosoc Nurs Ment Health Serv; 2012 Aug; 50(8):16-8. PubMed ID: 22801822
[TBL] [Abstract][Full Text] [Related]
34. "Spice" and "K2" herbal highs: a case series and systematic review of the clinical effects and biopsychosocial implications of synthetic cannabinoid use in humans.
Gunderson EW; Haughey HM; Ait-Daoud N; Joshi AS; Hart CL
Am J Addict; 2012; 21(4):320-6. PubMed ID: 22691010
[TBL] [Abstract][Full Text] [Related]
35. A comparison of symptoms and family history in schizophrenia with and without prior cannabis use: implications for the concept of cannabis psychosis.
Boydell J; Dean K; Dutta R; Giouroukou E; Fearon P; Murray R
Schizophr Res; 2007 Jul; 93(1-3):203-10. PubMed ID: 17462864
[TBL] [Abstract][Full Text] [Related]
36. [Psychotic disorders related with chronic use of mephedrone. Case report].
Urban M; Rudecki T; Wróblewski D; Rabe-Jabłońska J
Psychiatr Pol; 2011; 45(3):431-7. PubMed ID: 22232972
[TBL] [Abstract][Full Text] [Related]
37. [Cannabis and psychosis: search of a causal link through a critical and systematic review].
Le Bec PY; Fatséas M; Denis C; Lavie E; Auriacombe M
Encephale; 2009 Sep; 35(4):377-85. PubMed ID: 19748375
[TBL] [Abstract][Full Text] [Related]
38. Concurrent and Sustained Cumulative Effects of Adolescent Marijuana Use on Subclinical Psychotic Symptoms.
Bechtold J; Hipwell A; Lewis DA; Loeber R; Pardini D
Am J Psychiatry; 2016 Aug; 173(8):781-9. PubMed ID: 27138587
[TBL] [Abstract][Full Text] [Related]
39. Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings.
Hermanns-Clausen M; Kneisel S; Szabo B; Auwärter V
Addiction; 2013 Mar; 108(3):534-44. PubMed ID: 22971158
[TBL] [Abstract][Full Text] [Related]
40. Spice/K2 drugs--more than innocent substitutes for marijuana.
Zawilska JB; Wojcieszak J
Int J Neuropsychopharmacol; 2014 Mar; 17(3):509-25. PubMed ID: 24169044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
